23 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
or incident involving Sensitive Company Data.
(vv) No Broker Fees. Except as disclosed in the Prospectus, there are no contracts, agreements … with the transactions contemplated hereby, including without limitation (i) all expenses incident to the issuance and delivery of the Shares
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
to claims incident to the ordinary course of business. The Company was not a party to any material litigation and did not have any material contingency
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, and/or significant incident response, system restoration or remediation and future compliance costs. Any or all of the foregoing could materially … incident or breach or that the insurer will not deny coverage wholly or in part, of any future claim. Accordingly, if our cybersecurity measures
F-3
EX-1.2
MREO
Mereo Biopharma Group Plc
5 Aug 21
Shelf registration (foreign)
4:33pm
individual of any information security breach, compromise or incident involving Sensitive Company Data.
(vv) No Broker Fees. Except as disclosed … and in connection with the transactions contemplated hereby, including without limitation (i) all expenses incident to the issuance and delivery
6-K
EX-1.1
tlrlxjfokf0 z5y
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
F-3
EX-1.2
fngc8e2lqun v0h
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
9lkfi2 q02czejd
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
ob8c7n4
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
EX-10.1
educrh5cws5 p6d
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-10.2
11nvc zdbpvp
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
rem7p2m 8j5nrb
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
spfqeaurg
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-10.1
r2o m6yzeoy66x6rb
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
F-1
bcsn7iq852ocjl9z9j
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-10.1
ae7nov
10 Feb 20
Current report (foreign)
7:20am
20-F
72g94bvkj5
29 Apr 19
Annual report (foreign)
4:59pm
424B3
mf0 glzy0jf3s2rto
20 Mar 19
Prospectus supplement
4:58pm